Terms: = Liver cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Treatment
14 results:
1. Targeting lef1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
[TBL] [Abstract] [Full Text] [Related]
2. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
[TBL] [Abstract] [Full Text] [Related]
3. Possible Mechanism of Dysphania ambrosioides (L.) Mosyakin & Clemants Seed Extract Suppresses the Migration and Invasion of Human Hepatocellular Carcinoma Cells SMMC-7721.
Huang J; Hao J; Nie J; Qian R; Li H; Zhao J; Wang Y
Chem Biodivers; 2023 Mar; 20(3):e202200768. PubMed ID: 36694378
[TBL] [Abstract] [Full Text] [Related]
4. In vitro and Pharmacoinformatics-based phytochemical screening for anticancer impacts of pistachio hull essential oil on AGS, PLC/PRF/5, and CACO2 cell lines.
Askari N; Parvizpour S; Marashi SMB; Baghery F; Khanamani Falahati-Pour S
Mol Biol Rep; 2023 Jan; 50(1):465-473. PubMed ID: 36348196
[TBL] [Abstract] [Full Text] [Related]
5. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma.
Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S
Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537
[TBL] [Abstract] [Full Text] [Related]
6. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
Wan JL; Wang B; Wu ML; Li J; Gong RM; Song LN; Zhang HS; Zhu GQ; Chen SP; Cai JL; Xing XX; Wang YD; Yang Y; Cai CZ; Huang R; Liu H; Dai Z
Cancer Lett; 2022 Aug; 541():215750. PubMed ID: 35609735
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
Ragheb MA; Soliman MH; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
Anticancer Agents Med Chem; 2021; 21(2):237-245. PubMed ID: 32357822
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA lef1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-lef1/TSPAN8 Axis in Colorectal cancer.
Tanaka T; Kojima K; Yokota K; Tanaka Y; Ooizumi Y; Ishii S; Nishizawa N; Yokoi K; Ushiku H; Kikuchi M; Kojo K; Minatani N; Katoh H; Sato T; Nakamura T; Sawanobori M; Watanabe M; Yamashita K
Ann Surg Oncol; 2019 May; 26(5):1401-1411. PubMed ID: 30706227
[TBL] [Abstract] [Full Text] [Related]
10. Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway.
Fang S; Liu M; Li L; Zhang FF; Li Y; Yan Q; Cui YZ; Zhu YH; Yuan YF; Guan XY
Oncogene; 2019 May; 38(21):4061-4074. PubMed ID: 30696957
[TBL] [Abstract] [Full Text] [Related]
11. Repression of WT1-Mediated lef1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract] [Full Text] [Related]
12. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
[TBL] [Abstract] [Full Text] [Related]
14. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
[TBL] [Abstract] [Full Text] [Related]
